Edgestream Partners, L.P. Revolution Medicines, Inc. Transaction History
Edgestream Partners, L.P.
- $2.29 Billion
- Q4 2024
A detailed history of Edgestream Partners, L.P. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 7,779 shares of RVMD stock, worth $283,700. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,779
Previous 38,482
79.79%
Holding current value
$283,700
Previous $1.74 Million
80.49%
% of portfolio
0.01%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
297Shares Held
168MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$624 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$489 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$483 Million3.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$346 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY7.94MShares$289 Million3.85% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.2B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...